Mitochondrial DNA background modifies the bioenergetics of NARP/MILS ATP6 mutant cells
- PMID: 19875463
- PMCID: PMC2796897
- DOI: 10.1093/hmg/ddp503
Mitochondrial DNA background modifies the bioenergetics of NARP/MILS ATP6 mutant cells
Abstract
Mutations in the mitochondrial DNA (mtDNA) encoded subunit 6 of ATPase (ATP6) are associated with variable disease expression, ranging from adult onset neuropathy, ataxia and retinitis pigmentosa (NARP) to fatal childhood maternally inherited Leigh's syndrome (MILS). Phenotypical variations have largely been attributed to mtDNA heteroplasmy. However, there is often a discrepancy between the levels of mutant mtDNA and disease severity. Therefore, the correlation among genetic defect, bioenergetic impairment and clinical outcome in NARP/MILS remains to be elucidated. We investigated the bioenergetics of cybrids from five patients carrying different ATP6 mutations: three harboring the T8993G, one with the T8993C and one with the T9176G mutation. The bioenergetic defects varied dramatically, not only among different ATP6 mutants, but also among lines carrying the same T8993G mutation. Mutants with the most severe ATP synthesis impairment showed defective respiration and disassembly of respiratory chain complexes. This indicates that respiratory chain defects modulate the bioenergetic impairment in NARP/MILS cells. Sequencing of the entire mtDNA from the different mutant cell lines identified variations in structural genes, resulting in amino acid changes that destabilize the respiratory chain. Taken together, these results indicate that the mtDNA background plays an important role in modulating the biochemical defects and clinical outcome in NARP/MILS.
Figures








Similar articles
-
Whole mitochondrial genome analysis of a family with NARP/MILS caused by m.8993T>C mutation in the MT-ATP6 gene.Mol Genet Metab. 2012 Nov;107(3):389-93. doi: 10.1016/j.ymgme.2012.06.013. Epub 2012 Jul 10. Mol Genet Metab. 2012. PMID: 22819295
-
A yeast model of the neurogenic ataxia retinitis pigmentosa (NARP) T8993G mutation in the mitochondrial ATP synthase-6 gene.J Biol Chem. 2007 Nov 23;282(47):34039-47. doi: 10.1074/jbc.M703053200. Epub 2007 Sep 12. J Biol Chem. 2007. PMID: 17855363
-
Epilepsy in MT-ATP6 - related mils/NARP: correlation of elettroclinical features with heteroplasmy.Ann Clin Transl Neurol. 2021 Mar;8(3):704-710. doi: 10.1002/acn3.51259. Epub 2021 Jan 21. Ann Clin Transl Neurol. 2021. PMID: 33476484 Free PMC article.
-
Long-term outcome of Leigh syndrome caused by the NARP-T8993C mtDNA mutation.Am J Med Genet A. 2007 Sep 1;143A(17):2046-51. doi: 10.1002/ajmg.a.31880. Am J Med Genet A. 2007. PMID: 17663470 Review.
-
Pathogenesis of primary defects in mitochondrial ATP synthesis.Semin Cell Dev Biol. 2001 Dec;12(6):441-8. doi: 10.1006/scdb.2001.0281. Semin Cell Dev Biol. 2001. PMID: 11735378 Review.
Cited by
-
Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation.Hum Mol Genet. 2010 Aug 15;19(16):3190-205. doi: 10.1093/hmg/ddq229. Epub 2010 Jun 7. Hum Mol Genet. 2010. PMID: 20529956 Free PMC article.
-
Clinical Heterogeneity in MT-ATP6 Pathogenic Variants: Same Genotype-Different Onset.Cells. 2022 Jan 30;11(3):489. doi: 10.3390/cells11030489. Cells. 2022. PMID: 35159298 Free PMC article.
-
Induced pluripotent stem cells derived from patients carrying mitochondrial mutations exhibit altered bioenergetics and aberrant differentiation potential.Stem Cell Res Ther. 2023 Nov 7;14(1):320. doi: 10.1186/s13287-023-03546-7. Stem Cell Res Ther. 2023. PMID: 37936209 Free PMC article.
-
Modeling mitochondrial DNA diseases: from base editing to pluripotent stem-cell-derived organoids.EMBO Rep. 2023 Apr 5;24(4):e55678. doi: 10.15252/embr.202255678. Epub 2023 Mar 6. EMBO Rep. 2023. PMID: 36876467 Free PMC article. Review.
-
Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.Curr Pharm Des. 2011;17(31):3356-73. doi: 10.2174/138161211798072535. Curr Pharm Des. 2011. PMID: 21902672 Free PMC article. Review.
References
-
- Stock D., Leslie A.G., Walker J.E. Molecular architecture of the rotary motor in ATP synthase. Science. 1999;286:1700–1705. - PubMed
-
- Kinosita K., Jr, Yasuda R., Noji H., Ishiwata S., Yoshida M. F1-ATPase: a rotary motor made of a single molecule. Cell. 1998;93:21–24. - PubMed
-
- Noji H., Yasuda R., Yoshida M., Kinosita K., Jr Direct observation of the rotation of F1-ATPase. Nature. 1997;386:299–302. - PubMed
-
- de Vries D.D., van Engelen B.G., Gabreels F.J., Ruitenbeek W., van Oost B.A. A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome. Ann. Neurol. 1993;34:410–412. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions